Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Almac And Exco Working Together

March 24, 2011 11:41 am | News | Comments

The Almac Group and Exco InTouch announced that Almac’s Clinical Technologies business unit has formed a patient management alliance with Exco InTouch, an innovative firm specializing in patient recruitment, retention, compliance and ePRO services.

TOPICS:

ProImmune Receives GLP Certification

March 24, 2011 11:37 am | News | Comments

ProImmune Ltd. announced that it has been accepted into the UK GLP compliance monitoring program by the Medicines & Healthcare products Regulatory Agency formally confirming ProImmune’s compliance with GLP.

TOPICS:

Peptide Workstation

March 24, 2011 7:58 am | Product Releases | Comments

Biotage, a supplier of tools and technology for medicinal, analytical, and peptide chemistry, introduced the Biotage Initiator Peptide Workstation for manual microwave-assisted peptide synthesis.

TOPICS:
Advertisement

qPCR Assays

March 24, 2011 7:56 am | Product Releases | Comments

Integrated DNA Technologies (IDT) now offers PrimeTime Pre-designed qPCR Assays which are guaranteed to work for human, mouse, and rat transcriptomes.

TOPICS:

Diaphragm Pumps

March 24, 2011 7:52 am | Drug Discovery & Development | Product Releases | Comments

KNF LABOPORT Filtration Series diaphragm pumps provide ideal solutions for a wide range of applications in the lab, including flask filtration, vacuum blotting, vacuum manifold, and vacuum desiccation.

TOPICS:

RFID-Enabled Refrigerator

March 24, 2011 7:48 am | Product Releases | Comments

Terso Solutions, Inc. has expanded its line of RFID-enabled enclosures with the addition of a refrigerator that is well-suited for hospital and laboratory inventory management.

TOPICS:

Gentel-VARI Awarded Glycosylation Patent

March 24, 2011 7:45 am | News | Comments

Gentel Biosciences and Van Andel Research Institute jointly announced the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide.

TOPICS:

PerkinElmer to Buy CambridgeSoft

March 24, 2011 7:42 am | News | Comments

PerkinElmer, Inc., a global company focused on health and safety, announced that it has signed a definitive agreement to acquire CambridgeSoft Corporation, and has completed the purchase of ArtusLabs, Inc.

TOPICS:
Advertisement

Bird Embryo Provides Insight Into Cancer and Wound Healing

March 24, 2011 7:40 am | News | Comments

Avian embryos could join the list of model organisms used to study a specific type of cell migration called epiboly, thanks to the results of a study published this month in the journal Developmental Dynamics.

TOPICS:

Telomerase Inhibitor Also A Key Tumor Suppressor

March 24, 2011 7:36 am | News | Comments

It's been nearly 10 years since PinX1, the first potent endogenous protein shown to inhibit telomerase in mammals, was discovered. Now scientists have discovered a vitally important new function for this telomerase inhibitor.

TOPICS:

Prosensa Releases PRO051 Results

March 24, 2011 7:25 am | News | Comments

Prosensa, a biopharmaceutical company focusing on RNA modulating therapeutics, announces the publication of results from a phase 1/2 and 12-week extension study of its lead product, PRO051 for the treatment of Duchenne Muscular Dystrophy.

TOPICS:

Calcitonin Successful in Phase 3 Osteoporosis Trial

March 24, 2011 7:22 am | News | Comments

Tarsa Therapeutics announced that the Phase 3 ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.

TOPICS:

USP And FDA Updating Quality Standards

March 24, 2011 7:20 am | News | Comments

The U.S. Pharmacopeial Convention is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients.

TOPICS:

Safer, More Effective Morphine May Be Possible

March 24, 2011 7:17 am | News | Comments

An orphan drug originally used for HIV treatment has been found to short-circuit the process that results in additional sensitivity and pain from opioid use.

TOPICS:

Valeant CEO Adds Chairman to Title

March 24, 2011 7:15 am | News | Comments

Valeant Pharmaceuticals International Inc. said it named its CEO J. Michael Pearson to the additional post of chairman of the board. Pearson replaces Robert A. Ingram.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading